1. Elevated Serum CD95/FAS and HIF-1α Levels, but Not Tie-2 Levels, May Be Biomarkers in Patients With Severe Endometriosis: A Preliminary Report
    Savas Karakus et al, 2016, Journal of Minimally Invasive Gynecology CrossRef
  2. Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets
    Pedro Antônio Bronhara Pimentel et al, 2023, Veterinary Sciences CrossRef
  3. Histological and Molecular Biological Changes in Canine Skin Following Acute Radiation Therapy-Induced Skin Injury
    Sang-Yun Lee et al, 2024, Animals CrossRef
  4. Identification of hypoxia‐induced metabolism‐associated genes in canine tumours
    Taiki Kato et al, 2024, Veterinary and Comparative Oncology CrossRef
  5. Mammary Tumors in Dogs, Recent Perspectives and Antiangiogenesis as a Therapeutic Strategy: Literature Study
    Palagan Senopati Sewoyo et al, 2023, Jurnal Medik Veteriner CrossRef
  6. Metastasis prognostic factors and cancer stem cell-related transcription factors associated with metastasis induction in canine metastatic mammary gland tumors
    Saetbyul Kim et al, 2021, Journal of Veterinary Science CrossRef
  7. Molecular Markers in Canine Mammary Tumors
    Luciana-Mădălina Gherman et al, 2024, Acta Veterinaria CrossRef
  8. Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation
    Bianca Lara Venâncio de Godoy et al, 2023, Life Sciences CrossRef
  9. Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors
    Enni Markkanen, 2019, Frontiers in Cell and Developmental Biology CrossRef
  10. Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor
    Marina G. Moschetta et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  11. The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology
    Mark Gray et al, 2020, Frontiers in Veterinary Science CrossRef
  12. Global gene expression profile in canine mammary carcinomas
    G.R. Varallo et al, 2019, The Veterinary Journal CrossRef
  13. Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia
    Makchit Galadima et al, 2024, International Journal of Molecular Sciences CrossRef
  14. Current biomarkers of canine mammary tumors
    Ilona Kaszak et al, 2018, Acta Veterinaria Scandinavica CrossRef
  15. Evaluation of vascular endothelial growth factor gene and protein expression in canine metastatic mammary carcinomas
    Talita M.M. Raposo-Ferreira et al, 2016, Microscopy Research and Technique CrossRef